Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. LeBlond
A Head-To-Head Phase 3 Study Comparing BGB-3111 and Ibrutinib in Patients With Waldenström Macroglobulinemia
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Bruton's Tyrosine Kinase (Btk) Inhibitor BGB-3111 Demonstrates High Very Good Partial Response (Vgpr) Rate in Patients With Waldenström Macroglobulinemia (Wm)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ibrutinib Discontinuation in Waldenström Macroglobulinemia: Etiologies, Outcomes, and IgM Rebound
American Journal of Hematology
Hematology
PATIENT-REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB-RITUXIMAB IN THE INNOVATE STUDY
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Spotting the Elusive Siberian Tiger: Complete Response to Ibrutinib in a Patient With Waldenström Macroglobulinemia
American Journal of Hematology
Hematology
Waldenström Macroglobulinemia
Profiling of Circulating Exosomal miRNAs in Patients With Waldenström Macroglobulinemia
PLoS ONE
Multidisciplinary
A 50-Year-Long Study of Waldenström Macroglobulinemia
Mayo Clinic Proceedings
Medicine
CNS Vasculitis Associated With Waldenström Macroglobulinemia
Case Reports in Neurological Medicine
The Bone Marrow Microenvironment in Waldenström Macroglobulinemia
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
